Log In
BCIQ
Print this Print this
 

NK003

  Manage Alerts
Collapse Summary General Information
Company Neurokine Pharmaceuticals Inc.
DescriptionInterleukin-1 (IL-1) receptor antagonist (IL-1RA)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat discogenic back pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today